| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 30 | 20 |
-
|
-
| | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 30 | 20 |
-
|
-
| | | Operating Expenses | | Research Development | 1,619 | 1,025 | 1,188 | 1,060 | | Selling General and Administrative | 1,946 | 1,014 | 1,055 | 1,269 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 123 | 123 | 86 | 54 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,658) | (2,143) | (2,329) | (2,383) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,480) | 333 | 463 | 1,817 | | Earnings Before Interest And Taxes | (6,138) | (1,810) | (1,866) | (566) | | Interest Expense | 445 | 85 | 85 | 95 | | Income Before Tax | (6,583) | (1,895) | (1,951) | (661) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,583) | (1,895) | (1,951) | (661) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,583) | (1,895) | (1,951) | (661) | | Preferred Stock And Other Adjustments | (12) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,595) | ($1,895) | ($1,951) | ($661) |
|
0.50% Nasdaq 
Income Statement
